# FDA Inspection 1293950 - Albert Wiegman - November 13, 2025

Source: https://www.keypedia.com/records/fda_inspections/albert-wiegman/59e417a3-d177-4ddf-b9e1-6d9716733f25
Source feed: FDA_Inspections

> FDA Inspection 1293950 for Albert Wiegman on November 13, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1293950
- Company Name: Albert Wiegman
- Inspection Date: 2025-11-13
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1293950 - 2025-11-13](https://www.keypedia.com/records/fda_inspections/albert-wiegman/50b0a778-e841-4ec8-b42e-3705dd1f07bb)

Company: https://www.keypedia.com/companies/albert-wiegman/a83bd250-2fb5-406a-a9c7-80daf765f479

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c